Founder Eric Hoffman answers the judges' questions about @arthroventions's solution for joint care pic.twitter.com/evFY0cvlG4
— MedTech Innovator (@MedTechAwards) April 19, 2017
.@arthroventions uses 'snyoviomics' – biomarkers in the synovial fluid – to predict drug responsiveness for joint disease. pic.twitter.com/c5cMgIng7d
— Vanessa Carmean (@vanessacarmean) April 19, 2017